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A bstract
Background: Squamous cell carcinoma of the head and neck (SCCHN) often contain highly radioresistant hypoxic 
regions, nonetheless, radiotherapy is a common treatment modality for these tumours. Reoxygenation during 
fractionated radiotherapy is desired to render these hypoxic tumour regions more radiosensitive. Hypoxia additionally 
leads to up-regulation of PAI-1, a protein involved in tumour progression and an established prognostic marker for poor 
outcome. However, the impact of reoxygenation and radiation on PAI-1 levels is not yet clear. Therefore, we investigated 
the kinetics of PAI-l expression and secretion after hypoxia and reoxygenation, and determined the influence of ionizing 
radiation on PAI-l levels in the two human SCCHN cell lines, BHY and FaDu.
M ethods: HIF-l a  immunoblot was used to visualize the degree of hypoxia in the two cell lines. Cellular PAI-l expression 
was investigated by immunofluorescence microscopy. ELISA was used to quantify relative changes in PAI-l expression 
(cell lysates) and secretion (cell culture supernatants) in response to various lengths (2 -  4 h) of hypoxic exposure (<
0.66 % O2), reoxygenation (24 h, 20 % O2), and radiation (0, 2, 5 and l0 Gy).
Results: HIF-l a  expression was induced between 2 and 24 h of hypoxic exposure. Intracellular PAI-l expression was 
significantly increased in BHY and FaDu cells as early as 4 h after hypoxic exposure. A significant induction in secreted 
PAI-l was seen after l2 to 24 h (BHY) and 8 to 24 h (FaDu) hypoxia, as compared to the normoxic control. A 24 h 
reoxygenation period caused significantly less PAI-l secretion than a 24 h hypoxia period in FaDu cells. Irradiation led to 
an up-regulation of PAI-l expression and secretion in both, BHY and FaDu cells.
Conclusion: Our data suggest that both, short-term (~4 -  8 h) and long-term (~20 -  24 h) hypoxic exposure could 
increase PAI-l levels in SCCHN in vivo. Importantly, radiation itself could lead to PAI-l up-regulation in head and neck 
tumours, whereas reoxygenation of hypoxic tumour cells during fractionated radiotherapy could counteract the 
increased PAI-l levels.
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Background
The adverse effects of tum our hypoxia on the outcome 
after radiotherapy are well established for many different 
tum our types and in particular for SCCHN [1-4]. This is in 
part due to the oxygen effect; hypoxic cells require a 2.5 to 
3-fold higher radiation dose to achieve the same cell kill 
seen in well-oxygenated cells. Therefore, reoxygenation of 
hypoxic tumours during fractionated radiotherapy is 
intended to render tum our cells more radiosensitive. In 
addition, hypoxia causes a differential expression profile 
which can lead to a biologically more aggressive and radi­
oresistant phenotype.
One im portant protein that is up-regulated under hypoxic 
conditions is the plasminogen activator inhibitor type-1 
(PAI-1), a multifunctional protein, best known for its role 
as inhibitor of urokinase-type plasminogen activator 
(uPA) [5,6]. The activated serine protease uPA is able to 
convert plasminogen to plasmin, which in  turn degrades 
the extracellular matrix (ECM) and leads to invasion and 
metastasis of tum our cells. Despite its inhibiting function 
of uPA, numerous clinical studies demonstrate a strong 
correlation between high tissue levels of PAI-1 and poor 
prognosis for several tum our entities [7], including squa­
mous cell carcinomas of the head and neck [8,9]. This par­
adoxical finding might be explained by further biological 
functions of PAI-1 in promoting migration and angiogen- 
esis and in inhibiting apoptosis of tum our cells [10-13].
Previous studies have shown that both hypoxia inducible 
factors, HIF-1 and HIF-2, are able to transcriptionally up- 
regulate hum an PAI-1 via binding to the hypoxia respon­
sive element (HRE) within the PAI-1 promoter region 
[14,15]. An increase in PAI-1 mRNA has been observed in 
vitro as early as 2 h after hypoxic exposure in SCCHN, 
hum an hepatoma and lung cancer cell lines [14,16,17]. 
Only one detailed time-course analysis of cellular PAI-1 
expression levels after hypoxic exposure exists and was 
performed on a single hum an hepatoma cell line [14]. 
Up-regulation of PAI-1 protein secretion by low levels of 
oxygen has also been demonstrated in  various hum an cell 
lines, bu t so far not in  SCCHN [14,16,18,19]. Further­
more, very few studies -  and none on SCCHN -  exist 
investigating whether radiation can lead to enhanced PAI- 
1 levels [20-22].
As PAI-1 is a prognostic marker for poor outcome and is 
involved in  tum our progression, a better understanding of 
the factors (e.g., hypoxia and irradiation) responsible for 
PAI-1 up-regulation in SCCHN is vital for treatment plan­
ning of patients with these especially hypoxic and radiore­
sistant tumours. Therefore, the aim of our study was first 
to investigate the impact of the length of hypoxic exposure 
and reoxygenation on PAI-1 expression and secretion in 
the two hum an SCCHN cell lines, BHY and FaDu. Sec­
ondly, we examined the influence of ionizing radiation 
on PAI-1 expression and secretion in these same two cell 
lines.
Methods 
Cell lines
The two hum an cell lines, BHY and FaDu, were used in 
this study. BHY derives from a highly differentiated and 
invasive SCC from the lower alveolus (DSMZ ACC 404) 
[23] and FaDu originates from an undifferentiated 
hypopharyngeal SCC (ATCC HTB-43) [24]. Cells were 
cultured in Dulbecco's Modified Eagle's Medium (D- 
MEM) (Invitrogen) containing 10 % foetal calf serum 
(FCS), 0.05 mg/ml penicillin, 0.05 mg/ml streptomycin 
and 0.1 mg/ml neomycin and maintained in a humidified 
atmosphere of 95 % air and 5 % CO2 at 37°C (standard 
conditions).
Hypoxic cultivation o f cells
For hypoxia experiments, 5 x 105 cells were seeded into 10 
cm cell culture dishes. After 72 h pre-incubation under 
standard conditions, the medium was changed and the 
dishes were incubated for various lengths of time (2, 4, 8, 
12, 16, 20, 24 h) under normoxic (= standard conditions) 
or hypoxic conditions at 37°C. To achieve hypoxic condi­
tions, dishes were placed into airtight aluminium cham­
bers connected to a vacuum pum p and a N2 gas cylinder. 
By alternating eleven times between oxygen evacuation 
and N2 inflow, an oxygen concentration below 0.66 % (5 
mm Hg) was reached after 22 min.
For reoxygenation studies, cells were removed from the 
aluminium chambers after 24 h of hypoxia, then the 
medium was changed and cells were cultivated for an 
additional 24 h under normoxic conditions (24hH/ 
24hN). As a control, parallel samples were incubated for 
24 h under normoxia, then the medium was changed and 
cells were incubated further for 24 h under normoxic con­
ditions (24hN/24hN).
In addition, after 24 h of hypoxia, cell-free supernatants 
were transferred to fresh 10 cm cell culture dishes and 
incubated for 1, 2, 3 and 7 days under normoxic condi­
tions.
Trypan blue exclusion
This assay was used to determine the ratio of viable cells. 
Cells cultivated 24 h under normoxia or hypoxia were 
trypsinized, centrifuged, resuspended in  medium, and 
mixed with an equal volume of 0.4 % trypan blue staining 
solution. Viable and dead cells were counted using a 
haemocytometer.
Page 2 of 11
(page number not for citation purposes)
BMC Cancer 2007, 7:143 http://www.biomedeentral.eom/1471-2407/7/143
Irradiation
For irradiation experiments, 5 x 105 cells were seeded into 
10 cm cell culture dishes. After 72 h pre-incubation under 
standard conditions, the medium was changed and cells 
were irradiated with 2, 5 and 10 Gy using the RT100 irra­
diation device (Philips) at a dose rate of ~1 Gy/min. Irra­
diations were performed at room temperature under 
atmospheric conditions. Control cells received sham irra­
diation (= 0 Gy). After irradiation, cells were cultivated for 
45 h under standard conditions.
ELISA
Supernatants of cultured cells were centrifuged to remove 
debris and stored at -20° C. Attached cells were washed 
twice with cold PBS and lysed in 1 x TBST buffer (0.05 M 
Tris/HCl, pH 8.5, 0.1 M NaCl, 10 mM EDTA, 0.5 % 
Tween20 and 0.1 % Triton X-100). The cell suspension 
was rotated for 24 h at 4°C, centrifuged and the superna­
tant (= cell lysate) was stored at -20°C until further use. 
Protein content in the cell lysates was determined using 
the BCA™ Protein Assay Kit (Pierce). PAI-1 concentrations 
in the cell lysates and supernatants were determined by 
ELISA as described previously [25]. All measurements 
were performed in duplicate. The mean values and stand­
ard errors of the mean (S.E.M.) were calculated from at 
least three independent experiments.
For hypoxia and reoxygenation experiments, the PAI-1 
antigen content in cell lysates and supernatants was calcu­
lated relative to the total protein content in the corre­
sponding cell lysate. For the calculation of relative PAI-1 
levels, the PAI-1 concentrations in either cell lysates or 
supernatants at 24 h normoxia were set to one.
For irradiation experiments, the PAI-1 antigen concentra­
tion in cell lysates and supernatants was calculated rela­
tive to the viable adherent cells at the time point of sample 
collection. For the calculation of relative PAI-1 levels, PAI-
1 concentrations in the unirradiated samples (0 Gy) were 
set to one.
Western Blot
Cell lysates (5 |ig) were separated by SDS-polyacrylamide 
gel electrophoresis (10 %) and blotted onto a PVDF mem­
brane. Membranes were blocked 1 h at RT with 5 % non­
fat dry milk and 0.1 % Tween-20 in PBS. Subsequently, 
membranes were incubated with monoclonal anti- HIF- 
1a antibody (BD Biosciences Pharmingen, 1:250) or 
monoclonal anti-P-actin antibody (Sigma, 1:20000) at 
4°C overnight. After washing, the blots were incubated 
with secondary goat anti-mouse IgG horseradish peroxi­
dase conjugate (Promega, 1:2500) for 1 h at RT. Detection 
was performed with self-made ECL (1.25 mM Luminol,
0.2 mM p-Coumaric acid, 0.09% H2O2, 100 mM Tris/HCl 
pH 8.6). Cells treated with 100 |iM desferrioxamine
(DFO) for 24 h under standard conditions served as posi­
tive controls.
Immunofluorescence
For immunofluorescence studies, 5 x 105 cells were 
seeded onto 3-well diagnostic microscope slides (Erie Sci­
entific Company) in  10 cm cell culture dishes. After 72 h, 
the medium was exchanged and cells were exposed to nor- 
moxic or hypoxic conditions. Afterwards, cells were fixed 
with 4 % paraformaldehyde, permeabilized with saponin 
(0.025 %; 45 m in at RT) and subsequently incubated in 2 
% normal goat serum to block unspecific binding. Rabbit 
anti-PAI-1 antibody (PAb-Rb) [25] was diluted 1:125 
(FaDu) or 1:250 (BHY) in 0.1 % BSA-PBS and applied to 
the slides (4°C, O/N). Cells were stained in the dark for 
30 m in with Alexa Fluor® 488 goat anti-rabbit IgG (Invit- 
rogen) (1:400) to visualize PAI-1 and Alexa Fluor® 568 
phalloidin (Invitrogen) (1:100) to visualize the cytoskele- 
ton. Slides were then washed with PBS and m ounted with 
VECTASHIELD® Mounting Medium containing DAPI 
(Vector Laboratories). Fluorescence was observed using 
an Axioskop 2 plus fluorescence microscope (Zeiss) and 
the appropriate filters (Chroma Technology, BFIOptilas). 
Photographic documentation was carried out using an 
AxioCam MRc5 camera, an Achroplan 100 x oil objective 
and the AxioVision 4.4 software (Zeiss).
Statistics
Statistical analysis was performed using SPSS 12.0.1 soft­
ware. Student's t-test was used to evaluate the differences 
between normoxic, hypoxic and reoxygenated and 
between unirradiated and irradiated samples (*p < 0.05, 
**p  < 0.01, ** *p  < 0.001). Pearson's correlation coeffi­
cient r was used to determine linear correlations between 
intracellular and secreted PAI-1 levels.
Results
Hypoxia induces HIF-1 a  expression
Since HIF-1a (hypoxia inducible factor-1a) expression is 
known to increase after hypoxic exposure, HIF-1 a  was 
used to validate and visualize the hypoxic induction of 
cell metabolism in our system. Cells were incubated 
under normoxic (24 h) or hypoxic (2, 8, 16 and 24 h) con­
ditions and cell lysates prepared. As a positive control, 
cells were incubated for 24 h with 100 |iM desferroxamine 
(DFO) under aerobic conditions. Detection of HIF-1a by 
immunoblotting shows HIF-1a expression both under 
hypoxic conditions (2 -  24 h) and in DFO-treated BHY 
and FaDu cells, but no t under normoxic conditions (Fig.
1). HIF-1a levels increase in a time-dependent manner up 
to 8 h. From 8 h to 24 h, HIF-1a levels remain nearly con­
stant. This indicates that effective intracellular hypoxia 
was reached as early as 2 h after hypoxic incubation, 
increased up to 8 h and was stable for at least 24 h.
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Figure 1
HIF-1 a  expression in BHY and FaDu cell lysates. Cells 
were maintained under normoxia for 24 h (24hN) or hypoxia 
for 2 (2hH), 8 (8hH), 16 (l6hH) and 24 h (24hH). Cells 
treated with 100 |iM desferroxamine (DFO) for 24 h under 
normoxic conditions served as positive controls. 5 |ig of 
each cell lysate was loaded per well and visualized on west­
ern blots using HIF-l a  or P-actin antibodies as indicated.
Influence o f  hypoxia on cell viability
Before examining the effects of hypoxia on PAI-1 expres­
sion by BHY and FaDu cells, it was necessary to prove 
whether they could tolerate prolonged periods (24 h) 
under hypoxic conditions. The counting of cells in the cell 
culture supernatants revealed that 24 h hypoxia caused a 
significant detachment of cells (BHY: 29.0 %; FaDu: 13.9 
%) (Table 1). Additionally, since PAI-1 concentrations in 
later ELISA experiments were measured in  the cell lysates 
of adherent cells, it was essential to prove whether 24 h of 
hypoxia had an effect on the viability of the adherent cells. 
The determination of viability of the trypsinized adherent 
cells by the trypan blue exclusion assay demonstrated 
only a slight and non-significant decrease in  viability after 
24 h hypoxic exposure (BHY: 97.1 %; FaDu: 98.7 %) com­
pared to normoxic conditions (BHY: 99.1 %; FaDu: 99.4 
%) (Table 1).
Therefore, hypoxic exposure (24 h) causes increased 
detachment of cells, bu t does not lead to significant loss 
in  cell viability of the remaining adherent cells.
Influence o f  hypoxia on cell morphology and PAI-1 
expression
In order to observe cell morphology and PAI-1 expression 
under hypoxia, immunofluorescence studies were per­
formed. Cells were grown on slides, exposed to normoxic
Table 1: V ia b ility  o f  B H Y  and FaDu cells.
or hypoxic conditions and stained with an anti-PAI-1 anti­
body (PAb-Rb) and phalloidin. Staining with phalloidin 
(red) revealed no significant changes in the cytoskeleton 
during hypoxic incubation (Fig. 2). PAI-1 detection by 
PAb-Rb showed a strong green fluorescent signal in the 
cytoplasm after 8, 16 and 24 h of hypoxia in both cell 
lines, whereas the fluorescence of the normoxic control 
remained weak (Fig. 2). This demonstrates that hypoxia 
induces intracellular up-regulation of PAI-1 in BHY and 
FaDu cells.
Kinetics o f  cellular PAI-1 expression under hypoxia
To investigate the kinetics of PAI-1 expression under 
hypoxic conditions, BHY and FaDu cells were exposed 
either to normoxia for 2 and 24 h or to hypoxia for 2, 4, 
8, 12, 16, 20 and 24 h. Subsequently, the intracellular PAI-
1 levels were determined in cell lysates by ELISA. There 
was no significant difference in PAI-1 expression between
2 h and 24 h of normoxic incubation in BHY and FaDu 
cells. Therefore, cells incubated 24 h under normoxia were 
chosen as the standard for PAI-1 expression studies and 
hypoxic values were calculated relative to this value. A 
detailed kinetic analysis of hypoxia revealed a time- 
dependent increase in PAI-1 expression in BHY cells, start­
ing after 4 h and reaching maximal levels after 24 h of 
hypoxic exposure (Fig. 3A). FaDu cells showed the same 
tendency with significantly enhanced PAI-1 expression 
levels after 4 h, and maximal PAI-1 expression levels after 
20 h of hypoxia (Fig. 3B). The maximal relative induction 
of PAI-1 is 2.0-fold for BHY after 24 h hypoxia and 3.1- 
fold for FaDu after 20 h hypoxia.
Kinetics o f  PAI-1 secretion under hypoxia and normoxia
For the investigation of secreted PAI-1 levels, cells were 
exposed to the same normoxic and hypoxic conditions as 
for cellular expression studies. After 2, 4, 8, 12, 16, 20 and 
24 h, PAI-1 concentrations in the cell culture supernatants 
were measured. Importantly, an examination of FCS-con- 
taining D-MEM medium (without cells) revealed no 
detectable PAI-1.
Due to an increase in basal PAI-1 secretion levels from 2 
to 24 h normoxic incubation (BHY: 5.0-fold; FaDu: 4.8- 
fold), PAI-1 kinetics were studied not only under hypoxia 
bu t also under normoxia. As shown in figure 3C and 3D,
% detached cells % v iab le  a d h e re n t cells
24 h N 24 h H 24 h N 24 h H
B H Y 3.32 (± 0.57) 29.0 (± 2.36) *** 99.1 (± 0.35) 97.1 (± 1.24)
FaDu 0.73 (± 0.03) 13.9 (± 1.66) ** 99.4 (± 0.25) 98.7 (± 0.53)
A fter 24 h of normoxic o r hypoxic incubation, detached cells in the supernatants and trypsinized adherent cells were counted and the percentage 
of detached cells calculated. The percentage of viable adherent cells was determined by trypan blue exclusion assay. Mean values ± S.E.M. of at least 
four independent experiments are shown. Associated significance of hypoxic vs. normoxic cells is indicated (*p < 0.05, **p  < 0.01, ***p  < 0.001).
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Figure2
Influence of hypoxia on cell m orphology and PAI-1 
expression in BHY and FaDu cells. Immunofluorescent 
staining with the PAI-1 antibody, PAb-Rb (BHY 1:250, FaDu 
1:125) (green), Phalloidin (red) and DAPI (blue) of BHY and 
FaDu cells grown for 24 h under normoxic (24hN) and for 8 
(8hH), 16 (l6hH) and 24 h (24hH) under hypoxic conditions. 
Images of green fluorescence were consistently exposed for 
600 ms for BHY and 900 ms for FaDu.
the am ount of PAI-1 in the supematants of both cell lines 
rises with increasing lengths of both normoxic and 
hypoxic exposure. A significant difference in PAI-1 secre­
tion between normoxia and hypoxia exists from 12 to 24 
h for BHY and from 8 to 24 h for FaDu. The maximal dif­
ference between normoxic and hypoxic PAI-1 secretion 
was seen after 20 h for both cell lines (BHY: 1.7-fold; 
FaDu: 2.0-fold).
Under hypoxia, a similar time-dependent trend of intrac­
ellular (Fig. 3A and 3B) and secreted (Fig. 3C and 3D) PAI- 
1 levels exists for both cell lines. Accordingly, calculation 
of the Pearson's correlation coefficient, r, revealed a signif­
icant correlation between PAI-1 expression and secretion 
under hypoxia for BHY (r = 0.80, p < 0.05) as well as FaDu 
(r = 0.91, p < 0.01) cells.
Effect o f reoxygenation on PAI-1 expression and secretion
First, we investigated whether secreted PAI-1 in cell cul­
ture medium is detectable by ELISA after longer incuba­
tion periods at 37 °C. This was im portant for 
reoxygenation studies, since we intended to measure only 
PAI-1 that was secreted during the 24 h reoxygenation 
period and not during the preceding hypoxic exposure. 
For this, BHY and FaDu cells were exposed to hypoxic 
conditions for 24 h. Subsequently, the supernatants were 
centrifuged to remove detached cells and the cell-free 
supernatants were further incubated under standard con­
ditions at 37°C. At different time points (0, 1, 2, 3 and 7 
days), samples were drawn and PAI-1 concentrations in 
the cell-free supernatants were determined by ELISA. The 
PAI-1 levels in these cell-free supernatants remained con­
stant for up to 7 days, indicating that PAI-1 in the medium 
is detectable by ELISA after prolonged incubation periods 
at 37°C (Table 2).
Therefore, we decided to change the medium directly 
before reoxygenation. This ensured that only newly 
secreted PAI-1 protein during the 24 h reoxygenation 
period was measured. Two parallel dishes were exposed to 
hypoxia and two to normoxia for 24 h. Afterwards, cell 
lysates and supernatants from one of the hypoxic (= 
24hH) and one of the normoxic (= 24hN) dishes were 
prepared or isolated, respectively. In the remaining two 
dishes, the medium was changed (/indicates the medium 
change) and cells were kept for an additional 24 h under 
normoxic conditions (= 24hH/24hN and 24hN/24hN, 
respectively). In other words, 24hH/24hN is the reoxygen­
ated sample and 24hN/24hN is the normoxic control for 
medium changed dishes.
Measurements of PAI-1 concentrations in the cell lysates 
of BHY and FaDu cells revealed significantly higher PAI-1 
expression levels in hypoxic (24hH) and reoxygenated 
(24hH/24hN) than in normoxic (24hN) cells (Fig. 4A and 
4B). The PAI-1 expression in reoxygenated BHY and FaDu 
cells (24hH/24hN) was slightly less compared to hypoxic 
cells (24hH).
The supernatants of hypoxic BHY and FaDu cells (24hH) 
also revealed significantly increased PAI-1 levels com­
pared to normoxic cells (24hN) (Fig. 4C and 4D). During 
the 24 h reoxygenation period (24hH/24hN), less PAI-1 
was secreted than during the 24 h  hypoxic incubation 
period (24hH), which was significant for FaDu cells. The 
normoxic controls for the medium changed dishes 
(24hN/24hN) also showed slightly less PAI-1 secretion 
compared to the 24hN value, however to a lesser extent, 
indicating a net reduction in PAI-1 release during reoxy­
genation. These data demonstrate that although margin­
ally more PAI-1 is secreted during reoxygenation than 
under normoxia, clearly less is secreted than under 
hypoxia.
Irradiation induces PAI-1 expression and secretion
To prove whether irradiation has an effect on PAI-1 
expression and secretion, BHY and FaDu cells were irradi­
ated with 0, 2, 5 and 10 Gy under standard conditions. 
Measurement of PAI-1 concentrations relative to the 0 Gy 
control in the cell lysates and supernatants 45 h  after irra­
diation showed that both, PAI-1 expression and secretion, 
rises with increasing dose in both investigated cell lines 
(Fig. 5). Cellular PAI-1 levels were significantly increased 
after irradiation with 5 and 10 Gy in BHY cells and with 2 
and 10 Gy in FaDu cells (Fig. 5A and 5B). Maximal induc­
tion of PAI-1 expression was 3.6-fold for BHY and 6.5-fold 
for FaDu cells after irradiation with 10 Gy.
PAI-1 concentrations in the cell supernatants were also 
enhanced 45 h after irradiation (5 and 10 Gy) (Fig. 5C and 
5D), bu t only significantly for BHY cells. Maximal up-reg-
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Figure3
Kinetics of PAI-1 expression and secretion under hypoxia. A, B: Quantitative determination of PAI-1 levels in BHY (A)
and FaDu (B) cell lysates by ELISA. Cells incubated 24 h under normoxia were chosen as the normoxic standards for PAI-1 
expression studies and hypoxic values were calculated relative to these values (BHY: 33.5 ng/mg protein; FaDu: 8.6 ng/mg pro­
tein). Mean values ± S.E.M. of four independent experiments, each analyzed in duplicate, are shown. Associated significance of 
the hypoxic samples vs. the normoxic standard is indicated (*p < 0.05, **p < 0.01, ***p < 0.001). C, D: Quantitative determina­
tion of PAI-1 secretion levels in cell culture supernatants from BHY (C) and FaDu (D) cells by ELISA. The PAI-1 secretion level 
after 24 h normoxia was chosen as the normoxic standard (= 1) and all other values were calculated relative to this value 
(BHY: 706.5 ng/mg protein; FaDu: 112.8 ng/mg protein). Mean values ± S.E.M. of at least four independent experiments, each 
analyzed in duplicate, are shown. Associated significance between the hypoxic sample and the corresponding normoxic sample 
(2 -  24 h) is indicated (*p < 0.05, **p < 0.01, ***p < 0.001).
ulation of PAI-1 secretion was seen after irradiation with 
10 Gy (BHY: 3.4-fold, FaDu: 2.3-fold).
Discussion
As PAI-1 is involved in the invasion and migration of 
tumour cells and is an established marker for poor out­
come, it is crucial to investigate the exact mechanisms 
leading to increased PAI-1 levels. Although previous stud­
ies have shown that both, hypoxia and irradiation are able 
to up-regulate PAI-1 in different cell lines, no study has 
investigated the influence of hypoxia, reoxygenation and 
irradiation on PAI-1 expression and secretion in the fre­
quently hypoxic tum our entity, SCCHN. Therefore, in the 
present study, we investigated the influence of these 
parameters on PAI-1 expression and secretion in the two 
SCCHN cell lines, BHY and FaDu. Furthermore, we ana­
lyzed in detail the kinetics of PAI-1 induction by hypoxia.
The only data available so far on hypoxia kinetics for 
SCCHN cell lines is by Koong et al. [17]. However, they 
only investigated one cell line (FaDu) on the transcrip­
tional and not on the protein level. They found that PAI-
1 mRNA levels were enhanced already 2 h after hypoxic 
exposure and increased continuously up to 24 h.
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Table 2: D e tection  o f  PAI-1 in ce ll-free supernatants.
PAI-1 co n ce n tra tio n  [n g /m l]
Incuba tion  t im e  [d ] B H Y FaDu
0 66.3 (± 5.9) 9.8 (± 1.9)
1 66.8 (± 6.4) 10.5 (± 2.8)
2 61.0 (± 5.5) 10.2 (± 1.8)
3 66.9 (± 4.6) 9.8 (± 2.0)
7 73.3 (± 4.3) 10.4 (± 1.8)
Cells were maintained for 24 h under hypoxic conditions, then the 
cell-free supernatants were incubated at 37°C under standard 
conditions for up to  7 days. PAI-l concentrations [ng/ml] ± S.E.M. of 
three independent experiments, each analyzed in duplicate by ELISA 
are shown.
Concerning cellular PAI-1 protein levels, we showed sig­
nificantly increased PAI-1 levels during hypoxic exposure 
between 4 and 24 h for BHY and FaDu cells (Fig. 3A and 
3B). The only study describing detailed kinetics of cell- 
associated PAI-1 levels under hypoxia demonstrated a 
similar trend with significantly increased cellular PAI-1 
levels between 8 and 48 h  in the hum an hepatoma cell 
line, HepG2 [14].
Regarding secreted PAI-1 levels, a significant difference in 
PAI-1 secretion between normoxic and hypoxic cells 
began after 12 (BHY) or 8 h (FaDu) of incubation and 
lasted for up to 24 h  (Fig. 3C and 3D). In accordance with 
our results, Kimura et al. [16] demonstrated significant 
up-regulation of PAI-1 secretion after 8 and up to 24 h of 
hypoxic exposure for a hum an lung cancer cell line. Simi­
lar time-dependent studies on transformed and non­
transformed hum an and mouse cell lines showed signifi­
cantly elevated PAI-1 secretion levels starting between 6 
and 16 h  after hypoxic onset, depending on the investi­
gated cell line [14,26,27].
Taken together, these data show for SCCHN cell lines, that 
PAI-1 mRNA is induced very rapidly upon hypoxic expo­
sure (2 h) [17] with a short delay in PAI-1 expression 
(BHY and FaDu: 4 h) and an additional lag of some hours 
in PAI-1 secretion (FaDu: 8 h; BHY: 12 h). The study by 
Fink et al. [14] on the hum an hepatoma cell line, HepG2, 
confirms these results by demonstrating a lag in PAI-1 
protein synthesis behind the transcriptional up-regula­
tion. This time-lapsed hypoxic induction of PAI-1 mRNA, 
cellular protein and secreted protein can be explained by 
the sequence of RNA transcription, translation and secre­
tion.
Here, we report for the first time that in vitro hypoxia sig­
nificantly up-regulates cellular and secreted PAI-1 protein 
levels after short exposure times (4 -  8 h) and continues 
up to 24 h in two SCCHN cell lines. Additionally, we have 
shown an analogous PAI-1 up-regulation by hypoxia in
both cell lines, BHY and FaDu. Therefore, our data suggest 
that in vivo already short periods of hypoxia, e.g. caused by 
the closure of individual capillaries or by temporary 
reduction in blood flow (= acute hypoxia), might be suf­
ficient to up-regulate PAI-1 in SCCHN. Regarding radiore­
sistance, acutely hypoxic cells are believed to be a more 
serious problem than chronically hypoxic cells [28]. 
Therefore, acute hypoxia might be harmful in two ways; 
on the one hand by causing radioresistance and on the 
other hand by increasing PAI-1 levels, which most likely 
leads to a more aggressive phenotype of the surviving radi­
oresistant cells.
An association between high PAI-1 tum our tissue levels 
and poor outcome has been observed in many clinical 
studies for different tum our entities, so that PAI-1 has 
become an established prognostic marker [7-9]. As PAI-1 
is a secreted protein, it would be easier to measure PAI-1 
levels in the plasma of patients. Therefore, we compared 
PAI-1 expression and secretion levels during increasing 
lengths of hypoxic exposure and found a strong correla­
tion between intracellular (Fig. 3A and 3B) and secreted 
(Fig. 3C and 3D) PAI-1 levels in vitro. In vivo, no studies 
exist on SCCHN, however, a clinical study on breast can­
cer patients found no correlation between PAI-1 levels in 
tum our tissue and plasma [29]. The authors assume that 
this discrepancy might be due to inconsistent blood sam­
pling and/or processing. Nevertheless, in a small group of 
head and neck cancer patients, a relationship between 
increased PAI-1 serum levels and tum our hypoxia was 
detected [17]. As high amounts of PAI-1 are released from 
platelets upon coagulation, PAI-1 determination in blood 
plasma instead of serum probably would even have 
shown greater differences between more and less hypoxic 
tumours. Taken together, this suggests that PAI-1 plasma 
levels might indirectly reflect the hypoxic status of a 
tum our and implies that PAI-1 tum our and plasma levels 
could also correlate in vivo. Therefore, in vivo studies on 
SCCHN elucidating the correlation between tumour 
hypoxia, PAI-1 expression in tum our tissue and PAI-1 
plasma levels are promising, but should be performed 
under standardized blood sampling and processing con­
ditions.
Hypoxic cells require 2.5 -  3 times the radiation dose to 
produce the same level of cell kill as well-oxygenated cells. 
Therefore, radiation induced reoxygenation is intended to 
render hypoxic tum our cells more radiosensitive during 
fractionated radiotherapy. Indeed, Suzuki et al. [30] dem­
onstrated a significantly better local control for patients 
with reoxygenated cervical cancer. However, Dietz et al. 
[31] showed that a higher degree of tum our reoxygena­
tion during the initial course of chemoradiation or radio­
therapy is associated with a poor outcome in head and 
neck cancer patients. This phenom enon could be due to
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Figure 4
Effect of reoxygenation on PAI-1 expression and secretion. PAI-1 concentrations in cell lysates (A and B) and cell cul­
ture supernatants (C and D) of BHY and FaDu cells were determined by ELISA. Two parallel dishes were exposed to hypoxic 
conditions (■) and two to normoxic (□) conditions for 24 h. Subsequently, cell lysates and supernatants from one hypoxic (= 
24hH) and one normoxic (= 24hN) dish were prepared or isolated, respectively. In the remaining two dishes, the medium was 
changed (/indicates medium change) and cells were further kept for 24 h under normoxic conditions (= 24hH/24hN and 24hN/ 
24hN, respectively). Mean values ± S.E.M. of at least four independent experiments, each analyzed in duplicate, are shown rel­
ative to the mean normoxic value at the time of medium change (24hN). Associated significance of each sample vs. the nor­
moxic standard (24hN) is indicated (*p < 0.05, **p < 0.01, ***p < 0.001). Additionally, the significance of the reoxygenated 
sample (24hH/24hN) vs. the hypoxic sample (24hH) is indicated in D.
increased levels of harmful proteins, upon reoxygenation, 
e.g. proteins involved in tum our invasion and metastasis 
such as PAI-1. As PAI-1 functions outside the cell, secreted 
PAI-1 is especially crucial in promoting tum our progres­
sion. Most importantly, our results indicate that reoxygen­
ation leads to decreased PAI-1 secretion (Fig. 4C and 4D). 
Therefore, reoxygenation seems to be favourable not only 
with regard to increased radiosensitivity, but also with 
regard to reduced PAI-1 levels.
We are the first to demonstrate that irradiation induces 
PAI-1 expression and secretion in SCCHN cell lines (Fig. 
5). Our results confirm previous in vitro studies showing 
enhanced PAI-1 transcription and expression after ioniz­
ing radiation in non-transformed rat tubule epithelial 
cells [21] and increased PAI-1 transcription in hum an 
hepatoma cells [22]. In agreement with these in vitro 
results, Moeller et al. [20] observed enhanced PAI-1 
expression in vivo in irradiated murine breast tumours 
compared to non-irradiated tumours. As in vitro and in 
vivo studies have also demonstrated HIF-1a induction by 
radiation [20,32], we speculate that radiation induced 
PAI-1 up-regulation might occur via HIF-1a.
Conclusion
In summary, our data suggest that both, short-term (~4 -  
8 h) and long-term (~20 -  24 h) hypoxic exposure could 
increase PAI-1 levels in SCCHN in vivo. Additionally, our
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Figure5
PAI-1 expression and secretion a fte r irradiation. 45 h after irradiation with 2, 5 and 10 Gy, PAI-1 concentrations in the 
cell lysates (A and B) and cell culture supernatants (C and D) of BHY and FaDu cells were determined by ELISA. Unirradiated 
cells (0 Gy) served as a control. Mean values ± S.E.M. of three independent experiments, each analyzed in duplicate, are shown 
relative to the 0 Gy mean value. Associated significance of the irradiated samples vs. the unirradiated control (0 Gy) is indicated 
(*p < 0.05, **p < 0.01, ***p < 0.001).
results show that no t only hypoxia but also ionizing radi­
ation induces PAI-1 expression and secretion in SCCHN 
cell lines. This implies that radiation therapy, which is a 
common treatment modality for the frequently hypoxic 
head and neck tumours, could lead to enhanced PAI-1 
expression and secretion in vivo. On the other hand, reox­
ygenation of hypoxic tum our cells during fractionated 
radiotherapy could be favourable by counteracting the 
increased PAI-1 levels.
Therefore, future studies investigating the mechanisms 
(e.g. reactive oxygen species, HIF) behind hypoxic- and 
radiation-induced up-regulation of PAI-1 should help to 
develop strategies (antioxidants, HIF inhibitors) to pre­
vent increased PAI-1 expression and secretion and thereby 
improve the outcome after radiation therapy.
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